Current Challenges in Treating Unresectable Hepatocellular Carcinoma by Jean-François Dufour

Get full text

Should we undertake surveillance for HCC in patients with MAFLD? by Blanca Norero, Jean-François Dufour

Get full text

Surveillance for Hepatocellular Carcinoma in Patients with NASH by Philippe Kolly, Jean-François Dufour

Get full text

Nicotinamide and NAFLD: Is There Nothing New Under the Sun? by Maria Guarino, Jean-François Dufour

Get full text

Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma by Hwi Young Kim, Jean-François Dufour

Get full text

Hepatitis C: a changing epidemic by Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, Andri Rauch

Get full text

Potentials and pitfalls of clinical peptidomics and metabolomics by Alexander Benedikt Leichtle, Jean-François Dufour, Georg Martin Fiedler

Get full text

COVID-19 in Liver Transplant Recipients: A Systematic Review by Chiara Becchetti, Sarah Gabriela Gschwend, Jean-François Dufour, Vanessa Banz

Get full text

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients by Naomi F. Lange, Vanessa Graf, Cyrielle Caussy, Jean-François Dufour

Get full text

What Is the Role of Body Composition Assessment in HCC Management? by Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour

Get full text

Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic. by Olivier Schorr, Sarah Blach, Christine Thurnheer, Christian Ruis, Jean-Francois Dufour

Get full text

Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort by Susan Hutfless, Ruben Hernaez, Kuo-Tung Tang, Jean-François Dufour, Po-Hung Chen

Get full text

Endoplasmic Reticulum and Mitochondria Contacts Correlate with the Presence and Severity of NASH in Humans by Chaonan Jin, Eric Felli, Naomi Franziska Lange, Annalisa Berzigotti, Jordi Gracia-Sancho, Jean-François Dufour

Get full text

Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human by Sofia Tsouka, Pavitra Kumar, Patcharamon Seubnooch, Katrin Freiburghaus, Marie St-Pierre, Jean-François Dufour, Mojgan Masoodi

Get full text

Hepatic manifestations of drug reaction with eosinophilia and systemic symptoms syndrome by Maria Gabriela Delgado, Stefania Casu, Matteo Montani, Felix Brunner, Nasser Semmo, Annalisa Berzigotti, Jean François Dufour

Get full text

Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging by Patcharamon Seubnooch, Matteo Montani, Sofia Tsouka, Emmanuelle Claude, Umara Rafiqi, Aurel Perren, Jean-Francois Dufour, Mojgan Masoodi

Get full text

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review by Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa

Get full text

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm by Mandy Richani, Philippe Kolly, Marina Knoepfli, Evelyn Herrmann, Martin Zweifel, Hendrik von Tengg-Kobligk, Daniel Candinas, Jean-François Dufour

Get full text

Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease by Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti

Get full text

Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns by Oriol Juanola, Mohsin Hassan, Pavitra Kumar, Bahtiyar Yilmaz, Irene Keller, Cédric Simillion, Cornelius Engelmann, Frank Tacke, Jean-François Dufour, Andrea De Gottardi, Sheida Moghadamrad

Get full text